Locations:
Search IconSearch

How About a Dose of Empowerment for Your Next Chronic Back Pain Patient? (Video)

New program is all about shifting the power in pain management

Too often patients with chronic pain can be exceedingly passive, expecting their healthcare providers to be the main actors in “fixing” their pain. In the case of chronic low back pain, the result can sometimes be unneeded — and potentially harmful — prescriptions or spine injections, and occasionally even inappropriate and irreversible spine surgery.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Cleveland Clinic’s Neurological Institute is attempting to turn that dynamic on its head through a population health initiative for chronic low back pain that’s centered on the concept of empowering patients to take the lead in caring for their pain themselves. Spine neurosurgeon Edward Benzel, MD, who is directing the interdisciplinary initiative, explains the concept in this two-and-a-half-minute video.

We here at Cleveland Clinic see a huge number of chronic pain patients… These patients are often maybe mismanaged and/or could be managed in a more effective manner. We have developed a program to help deal with a small subset of this patient population, the early, chronic low-back pain patients, and trying to get them to a better place to manage their pain themselves from a non-surgical, minimizing-medicine perspective. The program is called the ‘Back on TREK’ program. It is appropriate for many people who have relatively early but chronic pain, and the pain’s been around for over several months, and they see no way out. Nothing has worked: injections, medications, etc., have not worked for them. When it is deemed by us that they don’t need surgery or other procedures… we try to get them into a program that causes them to be empowered to take care of their own pain problem. What often happens is we deal with passive patients, people who want to be healed… What we try to do is shift this empowerment… where the patient is trying to empower the physician to treat them, and we try to reverse that process and cause the patient to be empowered to treat themselves.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad